Forsterite/nano-biogenic hydroxyapatite composites for biomedical applications
Source abstract
Abstract
Recently, silicate materials have received attention as materials with promising applications in the bioceramics field. A recent study aimed to investigate the effect of forsterite (Mg2SiO4) addition to biogenic hydroxyapatite, Ca10(PO4)6(OH)2, on the phase formation, physical and mechanical properties, and biocompatibility of the produced composites. Different proportions of forsterite, 10 to 40 mass%, were added to hydroxyapatite obtained from fish bones to prepare the target composites. Various techniques, such as X-ray diffraction analysis (XRD), scanning electronic microscope (SEM), transmission electronic microscope (TEM), mechanical strength measurements and in vitro studies, were carried out to evaluate the composite properties. The results indicate that the addition of 20 to 40 mass% forsterite led to the transformation of forsterite into protoenstatite and the formation of Mg-rich whitlockite at the expense of hydroxyapatite. It is concluded that 20 mass% forsterite is the optimum addition amount to enhance the physical and mechanical properties of the produced composites. The cell culture tests and in vitro studies agree with the abovementioned results.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Bone Tissue Engineering Materials · Calcium Carbonate Crystallization and Inhibition · Dental materials and restorations
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Ceramics Department, National Research Centre, Cairo, Egypt
Faculty of Engineering, Materials Engineering Deptartment, Zagazig University, Zagazig, Egypt
IFKB, University of Stuttgart, Stuttgart, Germany
Clinic of Orthopedics and Traumatology, Musculoskeletal Research Laboratory, University Hospital Freiburg, Clinic of Surgery, Freiburg, Germany
Funding
Science & Technology Development Fund
References (39)
Show source-provided references
1. 10.1016/j.ceramint.2011.09.00810.1016/j.ceramint.2011.09.008 ↗
2. 10.1016/j.msec.2017.03.29010.1016/j.msec.2017.03.290 ↗
3. 10.1016/j.ceramint.2016.07.03710.1016/j.ceramint.2016.07.037 ↗
4. 10.1007/s10856-006-0544-510.1007/s10856-006-0544-5 ↗
5. 10.1016/j.proche.2016.03.00810.1016/j.proche.2016.03.008 ↗
6. 10.1142/202810.1142/2028 ↗
7. 10.1016/j.matlet.2007.01.02810.1016/j.matlet.2007.01.028 ↗
8. 10.1016/j.jallcom.2015.10.24010.1016/j.jallcom.2015.10.240 ↗
9. 10.1016/j.ceramint.2008.08.01710.1016/j.ceramint.2008.08.017 ↗
10. 10.1016/j.jmst.2018.06.01010.1016/j.jmst.2018.06.010 ↗
11. 10.1016/j.ceramint.2014.10.02510.1016/j.ceramint.2014.10.025 ↗
12. 10.1016/j.ceramint.2017.08.13210.1016/j.ceramint.2017.08.132 ↗
13. 10.1016/j.jallcom.2009.06.05110.1016/j.jallcom.2009.06.051 ↗
14. 10.1016/j.ceramint.2015.08.05710.1016/j.ceramint.2015.08.057 ↗
15. 10.1111/j.1151-2916.1981.tb10320.x10.1111/j.1151-2916.1981.tb10320.x ↗
16. 10.1002/jbm.82024060710.1002/jbm.820240607 ↗
17. Motwani SK · Eur J Pharm Biopharm · 2008 · 68 · 513
18. 10.1016/j.ceramint.2019.01.12210.1016/j.ceramint.2019.01.122 ↗
19. 10.1016/j.jeurceramsoc.2015.12.04510.1016/j.jeurceramsoc.2015.12.045 ↗
20. Naga SM · J Mater Sci · 2018 · 29 · 55
21. 10.1007/s11661-019-05433-410.1007/s11661-019-05433-4 ↗
22. 10.1111/j.1551-2916.2010.03817.x10.1111/j.1551-2916.2010.03817.x ↗
23. 10.1111/j.1744-7402.2010.02601.x10.1111/j.1744-7402.2010.02601.x ↗
24. 10.1016/0012-821X(93)90156-410.1016/0012-821X(93)90156-4 ↗
25. 10.1016/j.ceramint.2017.05.08310.1016/j.ceramint.2017.05.083 ↗
26. 10.1016/j.msec.2005.08.00510.1016/j.msec.2005.08.005 ↗
27. 10.1016/j.ceramint.2017.03.13010.1016/j.ceramint.2017.03.130 ↗
28. Thamaraiselvi TV · Trends Biomater Artif Organs · 2004 · 18 · 9
29. 10.1016/j.apt.2016.06.02310.1016/j.apt.2016.06.023 ↗
30. 10.1002/jbm.a.3183010.1002/jbm.a.31830 ↗
31. 10.2174/15672011280352976510.2174/156720112803529765 ↗
32. 10.1016/j.jallcom.2016.04.06810.1016/j.jallcom.2016.04.068 ↗
33. 10.1016/j.ceramint.2011.01.04510.1016/j.ceramint.2011.01.045 ↗
34. 10.1016/j.mseb.2009.11.01210.1016/j.mseb.2009.11.012 ↗
35. 10.1039/B611918M10.1039/B611918M ↗
36. 10.1126/science.106740410.1126/science.1067404 ↗
37. 10.1016/S0142-9612(03)00355-710.1016/S0142-9612(03)00355-7 ↗
38. Thamaraiselvi TV · Trends Biomater Artif Organs · 2004 · 18 · 9
39. 10.3390/ma1004042510.3390/ma10040425 ↗